M. Hemann

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies

M. Hemann, J. Chen, L. Abruzzo, 2012, Oncogene.

Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML

K. Stegmaier, M. Hemann, Å. Borg, 2015, Oncogene.

The p53–Bcl-2 connection

S. Lowe, M. Hemann, M. Hemann, 2006, Cell Death and Differentiation.